Deucravacitinib for the Treatment of Psoriatic Disease

Le, AM; Puig, L; Torres, T

Torres, T (通讯作者),Ctr Hosp Univ Porto, Dept Dermatol, Porto, Portugal.;Torres, T (通讯作者),Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022; 23 (6): 813

Abstract

Psoriasis is an immune-mediated disease, with the interleukin (IL)-23/IL-17 axis currently considered its main pathogenic pathway. Tyrosine kinase 2 (......

Full Text Link